Hula Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $250K

  • Investors
  • 2

Hula Therapeutics General Information

Description

Operator of an immunotherapy company intended to offer oncology care. The company helps to identify unique, functionally relevant, and essential tumor-specific targets and make them accessible to precision therapeutics which include cell therapy, thymus-derived cell engagers, bi-specifics, and antibody-drug conjugates, enabling healthcare professionals to offer treatment of adults and children with cancers.

Contact Information

Website
www.hulatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Philadelphia, PA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Philadelphia, PA
  • United States

Hula Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hula Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 22-Jul-2024 $250K Completed Startup
1. Early Stage VC 01-Jan-2024 Completed Startup
To view Hula Therapeutics’s complete valuation and funding history, request access »

Hula Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hula Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hatch Biofund Management Venture Capital Minority
BioAdvance Capital (Conshohocken) Venture Capital Minority
To view Hula Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Hula Therapeutics FAQs

  • When was Hula Therapeutics founded?

    Hula Therapeutics was founded in 2021.

  • Where is Hula Therapeutics headquartered?

    Hula Therapeutics is headquartered in Philadelphia, PA.

  • What is the size of Hula Therapeutics?

    Hula Therapeutics has 7 total employees.

  • What industry is Hula Therapeutics in?

    Hula Therapeutics’s primary industry is Drug Discovery.

  • Is Hula Therapeutics a private or public company?

    Hula Therapeutics is a Private company.

  • What is Hula Therapeutics’s current revenue?

    The current revenue for Hula Therapeutics is .

  • Who are Hula Therapeutics’s investors?

    Hatch Biofund Management and BioAdvance Capital (Conshohocken) have invested in Hula Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process